Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00296114 · ClinicalTrials.gov registry record
Pancreatic Cancer Serum and DNA Repository
A clinical trial, sponsored by Pancreatic Cancer Research Team.
- Completed
- Registry status
- 690
- Enrollment target
NCT00296114 is a clinical trial that has completed, run by Pancreatic Cancer Research Team. The registered enrollment target is 690 participants.
The verdict
NCT00296114 has completed, sponsored by Pancreatic Cancer Research Team.
- COMPLETED
- Registry status
- 690 participants
- Enrollment target
Study Summary
To prospectively collect serum and DNA samples from subjects with pancreatic cancer, pancreatitis, liver disease, and from healthy and at-risk volunteers in order to identify novel biomarkers for early diagnosis, differential diagnosis, stage, natural history of the disease, response to treatment, and to identify novel targets for therapeutic interventions. In particular:
Interventions
- PROCEDURE Serum and DNA Samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 690 participants |
| Start Date | 2004-02 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00296114
The ClinicalTrials.gov registry entry for NCT00296114 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 690 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pancreatic Cancer Research Team, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Serum and DNA Samples is the first listed.
NCT00296114 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00296114 about?
NCT00296114 is a clinical study titled "Pancreatic Cancer Serum and DNA Repository". To prospectively collect serum and DNA samples from subjects with pancreatic cancer, pancreatitis, liver disease, and from healthy and at-risk volunteers in order to identify novel biomarkers for early diagnosis, differential diagnosis, stage, natural history of the disease, response to treatment, a...
What is the current status of trial NCT00296114?
This trial is currently completed. The enrollment target is 690 participants. The study started on 2004-02. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00296114?
The interventions under investigation include: Serum and DNA Samples (PROCEDURE).
Who is sponsoring clinical trial NCT00296114?
This trial is sponsored by Pancreatic Cancer Research Team, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.